Lavendel

Mori HM, Kawanami H, Kawahata H, Aoki M. Wound healing potential of lavender oil by

acceleration of granulation and wound contraction through induction of TGF-β in a rat

model. BMC Complement Altern Med. 2016;16:144. doi:10.1186/s12906-016-1128-7

Vakilian K, Atarha M, Bekhradi R, Chaman R. Healing advantages of lavender essential oil

during episiotomy recovery: a clinical trial. Complement Ther Clin Pract. 2011;17(1):50–53.

Hagvall L, Bråred Christensson J. Patch Testing with Main Sensitizers Does Not Detect All

Cases of Contact Allergy to Oxidized Lavender Oil. Acta Derm Venereol. 2016;96(5):679–683.

doi:10.2340/00015555-2319

Jaramillo V., et al.: Enhancing Wound Healing: A Novel Topical Emulsion Combining CW49

Peptide and Lavender Essential Oil for Accelerated Regeneration and Antibacterial

Protection. Pharmaceutics 2023, 15, 1739.

Alberts A. et al.: Natural Products for Improving Soft Tissue Healing: Mechanisms,

Innovations, and Clinical Potential. Pharmaceutics 2025, 17, 758.

Koca Kutulu A. et al.: AComparison Study of Growth Factor Expression following Treatment

with Transcutaneous Electrical Nerve Stimulation, Saline Solution, Povidone-Iodine, and

Lavender Oil in Wounds Healing. Evidence-Based Complementary and Alternative

Medicine Volume 2013, Article ID 361832.

Marzouk T, Barakat R, Ragab A, Badria F, Badawy A. Lavender-thymol as a new topical

aromatherapy preparation for episiotomy: a randomised clinical trial. J Obstet Gynaecol.

2014;10:1–4.

Pharmakologie

ImmuneDefences: A View from the Side of the Essential Oils Vivian Tullio *,† , Janira Roana

†. Lorenza Cavallo andNarcisa Mandras. Molecules 2023, 28, 435.

Lavandula Species, Their Bioactive Phytochemicals, and Their Biosynthetic Regulation.

Miroslav Habán et al. Int. J. Mol. Sci. 2023, 24, 8831

How to Naturally Support the Immune System in Inflammation—Essential Oils as Immune

Boosters. Magdalena Grazul et al. Biomedicines 2023, 11, 2381

A review of the bioactive components and pharmacological properties of Lavandula species.

Gaber El‑Saber Batiha et al. Archives of Pharmacology (2023) 396:877

Botulinumtoxin

Botox treatment in patients with chronic functional anorectal pain: experiences of a tertiary

referral proctology clinic. R. E. Ooijevaar1 · R. J. F. Felt‑Bersma1,2 · I. J. Han‑Geurts2 · D.

van Reijn2 · P. F. Vollebregt1 · C. B. H. Molenaar2. Techniques in Coloproctology (2019)

23:239–244

Botulinum toxin injection for the treatment of chronic anal fissure: uni‑ and multivariate

analysis of the factors that promote healing Giuseppe Brisinda1,2 · Maria

Michela Chiarello3 · Anna Crocco4 · Anna Rita Bentivoglio1,5 · Maria Cariati3 · International

Journal of Colorectal Disease (2022) 37:693–700

Botox (onabotulinumtoxinA) mechanism of action Mitchell F. Brin, MDa,b,*, Rami

Burstein, PhDc Medicine (2023) 102:S1

Review Botulinum Toxin: A Comprehensive Review of Its Molecular Architecture and

Mechanistic Action Raj Kumar * and Bal Ram Singh Int. J. Mol. Sci. 2025, 26, 777

Review Botulinum Toxin Therapy: A Comprehensive Review on Clinical and Pharmacological

Insights Nahla Ayoub J. Clin. Med. 2025, 14, 2021

Botox treatment in patients with chronic functional anorectal pain: experiences of a tertiary

referral proctology clinic R. E. Ooijevaar1 · R. J. F. Felt‑Bersma1,2 · I. J. Han‑Geurts2 · D.

van Reijn2 · P. F. Vollebregt1 · C. B. H. Molenaar2 Techniques in Coloproctology

https://doi.org/10.1007/s10151-019-01945-8

Therapeutic use of Botulinum Toxin. J. Jankovic, M.F. Brin, NEJM 1991, Vol 324, pp 1186.

S3-Leitlinie: Analfissur AWMF-Registriernummer: 081-010 l. Marti et al,

coloproctology 2020 · 42:90–196

Jost S: Chronic anal fissures treated with botulinum toxin injections: a dose-finding study

withDysport((R)).Colorectal Dis1:26–28, 1999

S. Jost: Ten years' experience with botulin toxin in anal fissure October 2002 International

Journal of Colorectal Disease 17(5):298-302

Jost W.: One hundred cases of anal fissure treated with botulin toxin: Early and long-term

results 1997Diseases of the Colon & Rectum 40(9):1029-32

Brisinda G, Maria G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. A comparison of

injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic

anal fissure. N Engl J Med 1999; 341: 65–9.

Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A. A comparison of

botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med 1998; 338:

217–20.

Gui D, Cassetta E, Anastasio G, Bentivoglio AR, Maria G, Albanese A. Botulinum toxin for

chronic anal fissure. Lancet 1994; 344: 1127–8.

Botulinum Toxin (Botox®) Reduces Pain After Hemorrhoidectomy Davies, Justin

M.D.1; Duffy, David M.R.C.S.; Boyt, Nicholas M.R.Pharm.S.; Aghahoseini, Assad F.R.C.S.;

Alexander, David M.S.; Leveson, Stephen M.D. Diseases of the Colon & Rectum 46(8):p

1097-1102, August 2003. |

Botulinum Toxinvs.Topical Glyceryl Trinitrate Ointment for Pain Control in Patients

Undergoing Hemorrhoidectomy: A Randomized Trial Patti, Rosalia M.D.1; Luigi, Almasio

Piero M.D.2; Matteo, Arcara M.D.1; Sergio, Sammartano M.D.1; Pietro, Romano M.D.1;

Calogero, Fede Ph.D.3; Gaetano, Di Vita M.D.1,4 Diseases of the Colon & Rectum 49(11):p

1741-1748, November 2006

Postoperative outcomes of intrasphincteric botox injection during hemorrhoidectomy: A

double‑blind clinical trial Mina Alvandipour1, Mehdi Tavallaei2, Fatemeh Rezaei3, Hamed

Khodabakhsh4 Journal of Research in Medical Sciences 26(1):p 53, 2021

Botulinum toxin injection for management of post‑haemorrhoidectomy pain: an updated

systematic review and meta‑analysis of randomised clinical trials R. Quinn1,2 · G. Jamsari3 ·

S. Albayati1 Techniques in Coloproctology (2025) 29:96

Jost WH, Schimrigk K. Use of botulinum toxin in anal fissure. Dis Colon Rectum.

1993;36(10):974.

Nelson RL, Thomas K, Morgan J, Jones A. Non surgical therapy for anal fissure. Cochrane

Database Syst Rev. 2012;(2):CD003431.

Deutsche Gesellschaft für Koloproktologie (federführend). S3-Leitlinie Analfissur. AWMF-

Reg.-Nr. 081-010, 2020.

Davies J, Duffy D, Boyt N, et al. Botulinum toxin (Botox) reduces pain after

hemorrhoidectomy: results of a double-blind, randomized study. Dis Colon Rectum.

2003;46(8):1097–1102.

Quinn R, Jamsari G, Albayati S. Botulinum toxin injection for management of post-

haemorrhoidectomy pain: an updated systematic review and meta-analysis of randomised

clinical trials. Tech Coloproctol. 2025;29(1):96. doi:10.1007/s10151-025-03137-z

Alvandipour M, Safari S, Vahidpoor M, et al. Effect of intrasphincteric botulinum toxin on

postoperative urinary retention following stapled hemorrhoidopexy: a randomized, double-

blind, placebo-controlled trial. Sci Rep. 2026;16:22222. doi:10.1038/s41598-026-53489-1

Laser

Aibuedefe B, Kling SM, Philp MM, Ross HM, Poggio JL. An update on surgical treatment of

hemorrhoidal disease: a systematic review and meta-analysis. Int J Colorectal Dis.

2021;36:2041–9. 10.1007/s00384-021-03953-3. - DOI - PubMed

Karahaliloğlu AF. Erste Ergebnisse der Laserobliteration von erst- bis zweitgradigen

Hämorrhoiden. coloproctology. 2007;29:327–36. 10.1007/s00053-007-7029-y. - DOI

Sakr MF. LigaSure versus Milligan-Morgan hemorrhoidectomy: a prospective randomized

clinical trial. Tech Coloproctology. 2010;14:13–7. 10.1007/s10151-009-0549-4. - DOI -

PubMed

Zamlout A, Kasem M, El-Ayman Y, Allam K, Allam O, Helmy O, et al. Laser Hemorrhoidoplasty

versus LigaSure Hemorrhoidectomy for Grade II-IV Hemorrhoidal Disease: A Systematic

Review and Meta-Analysis. PROSPERO; 2026. - PMC - PubMed

Tümer H, Ağca MH. Comparing outcomes of laser hemorrhoidoplasty and LigaSure

hemorrhoidectomy in grade II–III hemorrhoidal disease: a retrospective analysis. ANZ J Surg.

2023;93:1885–9. 10.1111/ans.18568. - DOI - PubMed

Lakmal K, Basnayake O, Jayarajah U, Samarasekera DN. Clinical Outcomes and Effectiveness

of Laser Treatment for Hemorrhoids: A Systematic Review. World J Surg. 2021;45:1222–36.

10.1007/s00268-020-05923-2. - DOI - PubMed

Trigui A, Rejab H, Akrout A, Trabelsi J, Zouari A, Majdoub Y, et al. Laser utility in the

treatment of hemorrhoidal pathology: a review of literature. Lasers Med Sci. 2022;37:693–9.

10.1007/s10103-021-03333-x. - DOI - PubMed

al Ae (2024) Best clinical practice recommendations for the management of symptomatic

hemorrhoids via laser hemorrhoidoplasty: the LHP recommendations. Tech Coloproctol 29:2

Brusciano L, Gambardella C, Terracciano G, Gualtieri G, Schiano di Visconte M, Tolone S, Del

Genio G, Docimo L (2020) Postoperative discomfort and pain in the management of

hemorrhoidal disease: laser hemorrhoidoplasty, a minimal invasive treatment of

symptomatic hemorrhoids. Updates in Surgery 72:851–857

Faes S, Pratsinis M, Hasler-Gehrer S, Keerl A, Nocito A (2019) Short-and long-term outcomes

of laser haemorrhoidoplasty for grade II–III haemorrhoidal disease. Colorectal Disease

21:689–696

Thakur S (2023) Laser procedure for grade 2 and grade 3 haemorrhoids. International Journal

of Surgery 7:34–40